HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED was reported 36 times

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Somatostatin Analog [EPC] 1 0.0001
2 Provitamin D2 Compound [EPC] 2 0.0001
3 Estrogen Receptor Antagonist [EPC] 2 0.0000
4 Pyridone [EPC] 2 0.0000
5 Recombinant Human Growth Hormone [EPC] 1 0.0000
6 Aldosterone Antagonist [EPC] 7 0.0000
7 Histamine-1 Receptor Antagonist [EPC] 3 0.0000
8 Central Nervous System Stimulant [EPC] 2 0.0000
9 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
10 Methylxanthine [EPC] 1 0.0000
11 Nucleoside Analog Antiviral [EPC] 1 0.0000
12 Amide Local Anesthetic [EPC] 1 0.0000
13 Loop Diuretic [EPC] 5 0.0000
14 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
15 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
16 RANK Ligand Inhibitor [EPC] 2 0.0000
17 Aromatase Inhibitor [EPC] 1 0.0000
18 Sulfonylurea [EPC] 1 0.0000
19 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
20 Calcium [EPC] 1 0.0000
21 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
23 Kinase Inhibitor [EPC] 3 0.0000
24 Estrogen [EPC] 1 0.0000
25 Endothelin Receptor Antagonist [EPC] 1 0.0000
26 Expectorant [EPC] 1 0.0000
27 Mood Stabilizer [EPC] 1 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 Platinum-based Drug [EPC] 1 0.0000
30 Factor Xa Inhibitor [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 2 0.0000
32 Corticosteroid [EPC] 4 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 GLP-1 Receptor Agonist [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000